An antimetastatic study of Arg-Asp (RD) on salivary adenoid cystic carcinoma in vivo / 中华口腔医学杂志
Chinese Journal of Stomatology
; (12): 87-89, 2002.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-347362
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To test the antimetastatic effects of Arg-Asp (RD) on salivary adenoid cystic carcinoma (SACC-LM) in vivo.</p><p><b>METHODS</b>RD was administered orally to experimental metastasized nude mice. The pulmonary metastatic foci number and survival were determined to assay the antimetastatic effects of RD.</p><p><b>RESULTS</b>30 mg/kg, 120 mg/kg of RD demonstrated an inhibitory effect on the pulmonary metastatic foci formation. All of the tested dosages (7.5 mg/kg, 30 mg/kg, 120 mg/kg) of RD prolonged the survival.</p><p><b>CONCLUSIONS</b>Oral administration of RD has a antimetastatic effect on SACC-LM. RD is low toxicity.</p>
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Arginine
/
Salivary Gland Neoplasms
/
Aspartic Acid
/
Carcinoma, Adenoid Cystic
/
Therapeutic Uses
/
Dose-Response Relationship, Drug
/
Drug Therapy
/
Lung Neoplasms
/
Mice, Inbred BALB C
Limits:
Animals
/
Female
/
Humans
Language:
Chinese
Journal:
Chinese Journal of Stomatology
Year:
2002
Document type:
Article